Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV's pipeline of antimalarial drugs
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Malaria online course
Global health compound design webinars
Call for proposals
TPPs & TCPs
Learning resources for scientists
Project of the year award
Computational chemistry
R&D challenges
Access
Products & projects
Antimalarial drug availability
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Antimalarial drug toolkits
Artesunate injection dosage & administration
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
Access challenges
Partnering
The PDP model
Our partner network
Our donors
Current donors
Past donors
Donate to MMV
Intellectual property rights (IPR)
Clinical centre partners by country
Our impact
Milestones
Malaria stories from the field
Antimalarial drugs for children
Gender equity
Global health security
Antimicrobial resistance to antimalarials
Malaria and COVID-19
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
5 species of
Plasmodium
parasites
Lifecycle of malaria parasite
Malaria facts & statistics
Malaria treatment
History of antimalarial drugs
Newsroom
News & Press Releases
Audio
Media interviews
Speaking of Malaria podcast
Films
Infographics
Interviews
Image slideshows
Publications
Events
MMV Open
The Global Health Priority Box
About the Global Health Priority Box
Supporting information
Request the Global Health Priority Box
Terms & conditions
Malaria
Libre
Malaria
Libre
open innovation platform
Participate in Malaria
Libre
Malaria
Libre
data repository
MMVSola
About MMVSola
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
COVID Box
About the COVID Box
Supporting information
COVID Box terms and conditions
Archived projects
Pathogen Box
Malaria Box
MMV Open Team
Contact us
Home
Newsroom
News
News
Filter
All
R&D
Donors
General
Open source
Partner
Access & product management
All
R&D
Donors
General
Open source
Partner
Access & product management
55 found
WHO gives ‘strong recommendation’ supporting use of antimalarial drug to treat pregnant women in the first trimester
28 Nov 2022
MMV announces the start of ARCTIC, a feasibility study of a new
Plasmodium vivax
malaria treatment protocol
22 Jul 2022
MMV echoes Fight the Fakes Alliance’s call for Global Fund Replenishment to prevent increase in falsified medicines
14 Jul 2022
MMV deeply saddened by the loss of Dr Martin de Smet
01 Dec 2021
First real-world use of new protocol for
P. vivax
case management in Brazil – a Health Ministry and MMV collaboration
07 Oct 2021
SMC scale-up significantly reduces child mortality in the Sahel
10 May 2021
MMV’s partner S Kant receives WHO prequalification for its protective medicine for children
23 Apr 2021
Republic of Korea grants USD 10 million to MMV-led consortium to protect children from malaria in the Sahel
28 Jan 2021
MMV’s Adam Aspinall appointed as Chair of the new Fight the Fakes Alliance
14 Dec 2020
MMV launches new
P. vivax
malaria information hub
26 Jun 2019
Access to Medicines Index highlights role of collaboration in stimulating R&D
21 Nov 2018
Fosun Pharma’s medicine to protect pregnant women from malaria first to be approved by WHO
19 Nov 2018
Single-dose tafenoquine for radical cure of
P. vivax
malaria submitted for regulatory approval in Brazil
21 Sep 2018
Strides Shasun’s rectal artesunate product receives WHO prequalification
21 Jun 2018
WHO issues information note on correct use of rectal artesunate for severe malaria
18 Dec 2017
Unitaid awards MMV new supply side grant
08 Dec 2017
100 million vials of injectable artesunate distributed since 2010
06 Nov 2017
MMV and Transaid partner to tackle severe malaria in Zambia
31 Oct 2017
MMV and Aga Khan Foundation Canada come together to tackle malaria in Mali
01 May 2017
Cipla’s artesunate suppository first to be quality-assured by Global Fund
16 Dec 2016
MMV partner GSK ranked first in the Access to Medicine Index – again
17 Nov 2016
MMV welcomes WHO approval of 3-year shelf-life for antimalarial ASMQ
08 Mar 2016
Delivery of Coartem®
Dispersible
reaches a landmark of 300 million treatments
09 Dec 2015
European regulators grant Pyramax® a revised label
20 Nov 2015
Eurartesim® (dihydroartemisinin-piperaquine) receives WHO prequalification
26 Oct 2015
DNDi passes the ball to MMV
22 May 2015
MMV joins the Asia Pacific Malaria Elimination Network (APMEN)
23 Apr 2015
MMV recognizes outstanding achievements of ISMO partners
09 Apr 2015
Child-friendly antimalarial reaches new landmark of 250 million treatments delivered
19 Nov 2014
300,000 vials of injectable artesunate delivered to Kenya and Nigeria
04 Nov 2014
Guilin’s SP+AQ added to WHO’s “List of Prequalified Products”
29 Oct 2014
Pyramax now registered in Cambodia
15 Oct 2014
MMV launches the Seasonal Malaria Chemoprevention Tool Kit
29 Apr 2014
Eurartesim® begins ‘real-life’ post African registration safety and effectiveness testing
03 Oct 2013
WHO approves injectable artesunate 30mg & 120mg
24 May 2013
MMV and WHO launch new malaria map tool
25 Apr 2013
Eurartesim® (dihydroartemisinin-piperaquine) registered in first African country
07 Mar 2013
New pack for Injectable Artesunate (InjAS) accepted by WHO Prequalification
25 Feb 2013
MMV and partners handover SMS for Life in Tanzania to Government
07 Jan 2013
MMV to advance WHO-TDR’s pioneering studies on intrarectal artesunate
14 Dec 2012
UNITAID awards MMV-led consortium up to US$ 34 million
11 Dec 2012
Eurartesim® reaches Cambodia
19 Jul 2012
Scaling-up access to life-saving antimalarials in Nigeria
11 Jul 2012
Pyronaridine/artesunate included in the list of WHO prequalified medicines
15 May 2012
SMS for Life wins WSJ Innovation Award 2011
31 Oct 2011
Launch of the CAPSS Plus Pilot in Uganda
30 Sep 2011
MMV signs MoU with ALMA at the African Union Summit
03 Feb 2011
Malawi – determined to control malaria
14 Jul 2010
Ambrose Talisuna: Advocating for access
23 Apr 2010
MMV at ASTMH 2009
11 Nov 2009
MMV supports the need for subsidized antimalarials
12 Oct 2009
Price of Coartem® reduced for the third time in 8 years
13 Aug 2009
UNITAID supports new fund aimed at artemisinin extractors
19 May 2009
MMV applauds GFATM’s decision to host AMFm
11 Nov 2008
MMV welcomes the drop in price of life-saving Coartem®
23 Apr 2008